Lactiplantibacillus plantarum strains KABP011, KABP012, and KABP013 modulate bile acids and cholesterol metabolism in humans
Open accessThe DOI matches its Crossref record; 69 of the 71 references it cites were found in a registry or an index; 15 of the 25 sources its claims cite were checked for support.
Abstract
AIMS: Probiotics with high bile salt hydrolase (BSH) activity have shown to promote cardiovascular health. However, their mechanism(s) of action remain poorly understood. Here, we performed a pilot exploratory study to investigate effects of a 4-week intervention with escalating doses of a BSH-active formula containing Lactiplantibacillus plantarum strains KABP011, KABP012, and KABP013 on bile acid (BA), lipid profile, and lipoprotein function. METHODS AND RESULTS: Healthy overweight individuals were included in this study. The probiotic intake was associated with a progressive decrease of conjugated BAs in serum, due to the reduction of tauro- and glyco-conjugated forms. Plasma levels of fibroblast growth factor-19 were significantly reduced and correlated with BA changes. The probiotic induced significant changes in serum lipids, with reduction in non-HDL cholesterol (non-HDLc) and LDL cholesterol (LDLc) levels. The largest decrease was evidenced in the subgroup with higher baseline LDLc levels (LDLc > 130 mg/dL). Fasting levels of circulating apolipoprotein(Apo) B100 and ApoB48 were significantly reduced. Importantly, the decrease in non-HDLc levels was associated with a significant reduction in small LDL particles. Functional testing indicated that LDL particles had a significantly lower susceptibility to oxidation, while HDL particles gained antioxidant capacity after the probiotic intake. The microbiota profile in faeces collected at the end of the study was enriched with members of class Desulfovibrio, a taurine-consuming bacteria, likely because of the increase in free taurine in the gut due to the BSH activity of the probiotic. CONCLUSION: The intervention with L. plantarum strains induces beneficial effects on BA signature and lipoprotein profile. It reduces ApoB and small LDL levels and LDL susceptibility to oxidation and increases HDL antioxidant capacity. These metabolic profile changes suggest increased protection against atherosclerotic disease.
Overview
CoChat Summary
## TL;DR
In this 4-week single-arm pilot study of 20 healthy overweight adults, escalating doses of a BSH-active L. plantarum formula were associated with reduced conjugated bile acids, lower non-HDLc/LDLc, and improved lipoprotein function. The authors interpret these changes as a pattern potentially protective against atherosclerosis, but the design was exploratory and uncontrolled.
## Key findings
- Serum conjugated bile acids fell progressively during the intervention: by Day 14 they were 1.4-fold lower than baseline (P = 0.007) and by Day 28 they were 1.7-fold lower (P = 0.006); non-conjugated bile acids did not change.
- Plasma FGF-19 decreased significantly by the end of the intervention versus baseline (P = 0.011), and FGF-19 changes correlated with bile acid changes.
- Lipids improved: non-HDLc decreased significantly after 1 week by −6.2 mg/dL (P = 0.033), LDL particles became less susceptible to oxidation (P < 0.001), and HDL gained antioxidant capacity.
- ApoB100 and ApoB48 were significantly reduced after the first week and stayed reduced; small LDL particles also decreased, with the largest lipid reductions in the subgroup with baseline LDLc > 130 mg/dL.
## Methods
- Single-centre, single-arm, dose-escalation longitudinal intervention with a 2-week run-in and 4-week probiotic period; all participants received escalating weekly doses of AB-LIFE® containing L. plantarum KABP011, KABP012, and KABP013.
- Sample: 20 healthy overweight volunteers aged 25–60 years (10 men, 10 women); excluded were people with chronic disease, prior CVD, or lipid-lowering/other specified medications.
- Main analyses used serial blood and stool measures at baseline and Days 7, 14, 21, and 28, including bile acids by UHPLC-MS, lipoproteins by NMR, lipoprotein functionality assays, immunoassays, and microbiota profiling by 16S rRNA sequencing.
## Limitations
- The paper explicitly states the study’s limitations were the single-arm design and small sample size; it also notes that a placebo effect cannot be excluded.
- The authors also state that the stool sampling was only a spot sample, which did not allow measurement of total fecal bile acid excretion.
- Evident from the text: the study population was limited to 20 healthy overweight adults without major comorbidity, so generalizability to hypercholesterolaemic or diseased populations is uncertain.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
13 Valid · 1 Not valid · 8 Not checked · 120 Own results and interpretations
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“This activity could influence lipid metabolism and cholesterol levels in the host through the activation of specific signalling pathways.14,17”
§ Lactiplantibacillus plantarum strains KABP011, KABP012, and KABP013 modulate bile acids and cholesterol metabolism in humans > Introduction
What the sources say
- Not checked — no full text of the sourcecites [14] Molinaro, 2018, Role of bile acids in metabolic control, Trends Endocrinol Metab source
- Supportedcites [17] Joyce, 2015, Bacterial bile salt hydrolase in host metabolism: potential for influencing gastrointestinal microbe-host crosstalk, Gut Microbes source
The opening summary reports that BSH expression altered lipid and cholesterol metabolism and signaling functions in mice. The section “Gut Associated BSH Activity Alters Host Weight Gain and Specific Host Metabolic Pathways” reports regulation of metabolic effector pathways and lower serum cholesterol; “Bile Salt Hydrolase Distribution and Potential Function” identifies bile-acid signaling through FXR and TGR5. Together these support the claim’s tentative wording. (LLM, conf=0.91)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“This process implies a downregulation of key regulators of energy and lipid metabolism such as the nuclear farnesoid X receptor (FXR)/fibroblast growth factor-19 (FGF-19) feedback loop in humans (FXR/FGF-15 in mice).17”
§ Lactiplantibacillus plantarum strains KABP011, KABP012, and KABP013 modulate bile acids and cholesterol metabolism in humans > Introduction
What the sources say
- Partly supportedcites [17] Joyce, 2015, Bacterial bile salt hydrolase in host metabolism: potential for influencing gastrointestinal microbe-host crosstalk, Gut Microbes sourceExperimental — accuracy not yet measured
The References section cites a mouse study reporting downregulation of the FXR–FGF15 axis, and the ‘Potential Effectors in our System’ section lists that axis among possible effects. Our copy does not establish that the process downregulates an FXR–FGF19 feedback loop in humans; it describes the authors’ BSH findings in mice and treats other metabolic effects as potential mechanisms. No page number is available in our copy. (LLM, conf=0.82)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Specific probiotics, in particular Lactobacillus species (sensu lato), have shown BSH activity.16”
§ Lactiplantibacillus plantarum strains KABP011, KABP012, and KABP013 modulate bile acids and cholesterol metabolism in humans > Introduction
What the sources say
- Supportedcites [16] Prete, 2020, Beneficial bile acid metabolism from Lactobacillus plantarum of food origin, Sci Rep source
The Introduction identifies Lactobacillus, including Lb. plantarum, among genera characterized for BSH deconjugation activity. The Discussion also reports bile-acid deconjugation by the food-borne Lb. plantarum strains studied, while noting strain-specific variation. (LLM, conf=0.94)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“The effects of probiotics on cholesterol lowering seem to be mediated by the modulation of the bile acid (BA) metabolism in the gut.11,12”
§ Lactiplantibacillus plantarum strains KABP011, KABP012, and KABP013 modulate bile acids and cholesterol metabolism in humans > Introduction
What the sources say
- Supportedcites [11] Begley, 2006, Bile salt hydrolase activity in probiotics, Appl Environ Microbiol source
The “Cholesterol lowering” section says probiotic cholesterol-lowering effects can be partially ascribed to bile salt hydrolase activity. It explains how bile-salt deconjugation could reduce serum cholesterol, while acknowledging other possible mechanisms. (LLM, conf=0.90)
- Supportedcites [12] Martoni, 2015, Changes in bile acids, FGF-19 and sterol absorption in response to bile salt hydrolase active L. reuteri NCIMB 30242, Gut Microbes source
The Introduction describes bile salt hydrolase–mediated bile acid deconjugation in the gut as a process involved in cholesterol regulation. The Discussion reports that the probiotic increased circulating bile acids while improving LDL cholesterol, and that bile acid increases were inversely associated with markers of cholesterol absorption. This supports the citing sentence’s tentative mechanistic claim. (LLM, conf=0.88)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“In the case of probiotics with typical BSH activity, the process is likely related to the deconjugation of conjugated BAs.32,33”
§ Lactiplantibacillus plantarum strains KABP011, KABP012, and KABP013 modulate bile acids and cholesterol metabolism in humans > Discussion
What the sources say
- Supportedcites [32] Baars, 2015, The gut microbiota as a therapeutic target in IBD and metabolic disease: a role for the bile acid receptors FXR and TGR5, Microorganisms source
Section 8, “Dietary Interventions with Pro or Synbiotics,” explicitly describes bile salt hydrolase (BSH)-active probiotics deconjugating bile acids. It presents reduced bile-acid reabsorption and increased excretion, followed by bile-acid synthesis that reduces plasma cholesterol, as a potential cholesterol-lowering mechanism. (LLM, conf=0.94)
- Not checked — no full text of the sourcecites [33] Choi, 2015, Probiotics and the BSH-related cholesterol lowering mechanism: a Jekyll and Hyde scenario, Crit Rev Biotechnol source
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
74 more claims
Create a free account to see all 142 claims and to verify the 2 references still open.
- Probably not a substantial claim. 15
- It may state two separate claims as one. 52
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482 · cited 2×
“Anthropometric measurements, blood pressure, serum lipid profile, and biochemical measurements were determined at baseline and at Days 7, 14, 21, and 28 (see Supplementary material online, Figure S1 ).”
BackgroundMethodInfluentialHill (2014) · doi:10.1038/nrgastro.2014.66 · Cited by 9,592 · cited 1×
“9 However, different probiotic strains present unique characteristics and consequently strain-specific effects should be considered when searching for specific indications for administration as supplements with therapeutic properties.”
BackgroundPlasma Concentrations of a Novel, Adipose-Specific Protein, Adiponectin, in Type 2 Diabetic Patients
Hotta, K., Funahashi, T., Arita, Y., Takahashi, M., Matsuda, M., Okamoto, Y., Iwahashi, H., Kuriyama, H., Ouchi, N., Maeda, K., et al. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.6.1595 · Cited by 3,133 · cited 1×
“55 In our study of volunteers without a pro-inflammatory baseline condition (healthy, non-smoking population with a BMI 30 kg/m 2 ), we did not detect major changes in any of the inflammatory markers investigated, including CRP, TNF-alpha, GlycA, GlycB, and ILs such as IL-1 β , IL-6, IL-8, IL-12,…”
BackgroundGut biogeography of the bacterial microbiota
Donaldson, G. P., Lee, S. M., & Mazmanian, S. K. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro3552 · Cited by 2,535 · cited 1×
“…salt absorption occurs in the distal ileum, 40,64 where microbial density is 10 7 –10 8 CFU/mL, much lower than in the colon at ∼ 10 12 CFU/mL. 65,66 Therefore, probiotics could significantly impact ileal microbiota (where BA reabsorption occurs), while faecal microbiota remains mostly unchanged…”
BackgroundBile Salt Hydrolase Activity in Probiotics
Begley, M., Hill, C., & Gahan, C. G. M. (2006) · Applied and Environmental Microbiology · doi:10.1128/aem.72.3.1729-1738.2006 · Cited by 1,187 · cited 3×
“11,14 BAs are efficiently conserved under normal conditions by means of the enterohepatic circulation.”
BackgroundDawson, P. A., Lan, T., & Rao, A. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r900012-jlr200 · Cited by 680
Interaction of gut microbiota with bile acid metabolism and its influence on disease states
Staley, C., Weingarden, A. R., Khoruts, A., & Sadowsky, M. J. (2017) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-016-8006-6 · Cited by 581 · cited 1×
“68 Further studies are needed to better define whether changes in BA conjugation after the L. plantarum intervention are only dependent on the Lactobacillus BSH activity or also related to probiotic-mediated changes in the gut microbiota.”
BackgroundDi Ciaula, A., Garruti, G., Lunardi Baccetto, R., Molina-Molina, E., Bonfrate, L., Wang, D. Q.-H., & Portincasa, P. (2017) · Annals of Hepatology · doi:10.5604/01.3001.0010.5493 · Cited by 569 · cited 1×
“38 However, human bile contains three times more glycine-conjugated BAs than taurine forms 39 supporting the notion that taurine availability is a limiting factor for de novo BA conjugation.”
BackgroundHow Probiotics Affect the Microbiota
Wieërs, G., Belkhir, L., Enaud, R., Leclercq, S., Philippart de Foy, J.-M., Dequenne, I., de Timary, P., & Cani, P. D. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00454 · Cited by 525 · cited 1×
“63 It should be taken into account that bile salt absorption occurs in the distal ileum, 40,64 where microbial density is 10 7 –10 8 CFU/mL, much lower than in the colon at ∼ 10 12 CFU/mL. 65,66 Therefore, probiotics could significantly impact ileal microbiota (where BA reabsorption occurs), while…”
Background
Cited by
The role of probiotics in personalized therapeutics: Advances in gut microbe-driven interventions
Manan, M. A. (2025) · The Microbe · doi:10.1016/j.microb.2025.100497 · Cited by 68
Zhang, H., Wang, J., Shen, J., Chen, S., Yuan, H., Zhang, X., Liu, X., Yu, Y., Li, X., Gao, Z., et al. (2024) · iMeta · doi:10.1002/imt2.220 · Cited by 37
“Besides the production of metabolites such as trimethylamine (TMA) [6, 11], short ‐ chain fatty acids (SCFAs) [12, 13], bile acids [14, 15], and succinates [16, 17], the gut microbiome also plays a crucial role in regulating the host ′ s immune and inflammatory responses via the modulation of…”
BackgroundProbiotics: A Potential Strategy for Preventing and Managing Cardiovascular Disease
López‐Yerena, A., Villaplana, V. D. S., Badimón, L., Vilahur, G., & Padró, T. (2024) · Nutrients · doi:10.3390/nu17010052 · Cited by 24
Self-citationLiu, H., Ma, X., Yang, X., Xiao, S., Ouyang, S., Hu, Z., Zhou, Z., & Jiang, Z. (2024) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2024.151642 · Cited by 17
Bile salt hydrolase: A key target for developing high-performance probiotics
Liu, S., Ye, L., Feng, L., Luo, B., Chen, J., Xu, Q., & Zhang, L. (2025) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2025.105383 · Cited by 10
Metadata
- Authors
- Padro, T., Santisteban, V., Huedo, P., Puntes, M., Aguiló, M., Espadaler-Mazo, J., & Badimon, L.
- Affiliations
- Cardiovascular Program-ICCC, Institut d’Investigació Biomèdica Sant Pau (IIB SANT PAU) , Sant Antoni Mª Claret 167, Barcelona 08025 , Spain
- Universitat Internacional de Catalunya (ES)
- Medicament Research Center (CIM), Institut d’Investigació Biomèdica Sant Pau (IIB SANT PAU) , Barcelona , Spain
- AB-Biotics (Spain) (ES)
- R&D Department, AB-Biotics S.A. (Part of Kaneka Corporation) , Barcelona , Spain
- ORCID
- Venue
- Cardiovascular Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2024-03-25
- Volume
- 120
- Issue
- 7
- Pages
- 708-722
- ISSN
- 0008-6363 (ISSN-L)
- 1755-3245
- PMC
- PMC11135648
- OpenAlex
- W4393158089
- Cited by
- 32
- References
- 71
- Citations by year
- 2026: 15 · 2025: 11 · 2024: 6
- FWCI
- 6.85
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Cardiovascular Research (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Dipòsit Digital de Documents de la UAB (Universitat Autònoma de Barcelona) (submittedVersion, cc-by)
- Funders
- AB-Biotics SA
- Spanish Ministry of Economy and Competitiveness of Science ‘Agencia Estatal de Investigación (AEI/10.13039/501100011033, PID2019-107160RB-I00)
- Institute of Health Carlos III (FIS PI19/01687)
- Topics
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Keywords
- Lactobacillus plantarum, bile salt hydrolase, probiotics, bile acids, cholesterol metabolism, LDL cholesterol, non-HDL cholesterol, FGF19, apolipoprotein B, small dense LDL, LDL oxidation, HDL antioxidant capacity, taurine, Desulfovibrio, gut microbiota, overweight, atherosclerosis, cardiovascular health
- MeSH terms
- Gastrointestinal Microbiome, Adult, Amidohydrolases, Bile Acids and Salts, Cholesterol, Female, Fibroblast Growth Factors, Humans, Cholesterol, LDL, Male, Middle Aged, Pilot Projects, Time Factors, Biomarkers, Treatment Outcome, Probiotics, Lactiplantibacillus plantarum, Apolipoprotein B-48, Apolipoprotein B-100
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Lactiplantibacillus plantarum strains KABP011, KABP012, and KABP013 modulate bile acids and cholesterol metabolism in humans. https://app.cochat.ai/papers/10.1093/cvr/cvae061
- The paper
- Padro, T., Santisteban, V., Huedo, P., Puntes, M., Aguiló, M., Espadaler-Mazo, J., & Badimon, L. (2024). Lactiplantibacillus plantarum strains KABP011, KABP012, and KABP013 modulate bile acids and cholesterol metabolism in humans. Cardiovascular Research. https://doi.org/10.1093/cvr/cvae061
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.